Preventative nasal spray shown to reduce viral replication by up to 96% in COVID-19 challenge study
A four-part article on Uniseed’s journey over the past 20 years. Each week in September, we will post a chapter covering the subsequent 5 years in Uniseed’s journey. Part 1 - 2000 - 2005 Part 2 - 2006 - 2010 Part 3 - 2011 - 2015 Part 4 - 2016 - 2020
Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years
Uniseed CEO Peter Devine talks with Global University Venturing’s Thierry Heles about Uniseed’s journey over the past 20 years.
Uniseed investee company Hatchtech, developing an innovative prescription head lice product, today announced that its commercialisation partner, Dr Reddy’s Laboratories, has achieved US Food and Drug Administration (FDA) approval of Xeglyze ….
Nanotech company Ferronova secures BioMedTech Horizons Grant Uniseed investee Ferronova Pty Ltd has been awarded an $826,000 grant from the Australian Government’s BioMedTech Horizons (BTMH) program, operated by MTPConnect to further its nanoparticle development...
Uniseed and BioCurate sign early stage research commercialisation agreement Melbourne, 17 June, 2020 – BioCurate, an independently-operated joint venture between the University of Melbourne and Monash University, has entered into an agreement with leading Australian...
Nanotech company Ferronova secures $3.5m Series A funding led by Uniseed: Australian biotechnology company Ferronova Pty Ltd today closed a $3.5 million Series A financing round to fund clinical trials of its cancer tracing nanoparticle designed to find secondary cancer cells more accurately during cancer surgery.
MEDIA Release Q-Sera Pty Ltd and JHL Biotech, Inc.
Medibank Heart Health at Home app powered by Cardihab
PERKii® Probiotics’ new Apple and Ginger flavour is the latest probiotic drink out of the PERKii® lab, made with over 1 billion probiotics. “COVID-19 is having a devastating impact on people’s lives in Australia ….